ResistancePlus® GC

Neisseria gonorrhoeae

Sexually Transmitted Disease Surveillance Report 2020:
Gonococcal Isolate Surveillance Project Site-Specific Profiles

STD clinics affiliated with 33 state or city health departments contributed 3,741 gonococcal isolates to GISP in 2020. Of these 33 sites, 10 current sites have participated continuously since 1987. This data represents the percentage of isolates with resistance to ciprofloxacin, gathered for the Gonococcal Isolate Surveillance Project (GISP), 2001-2020.


n = number of ciprofloxicin resistant participants in the state for each year
% = proportion of ciprofloxicin resistant participants versus the total participants for the state for each year

US interactive GC Cipro Map

Percentage of Isolates with Resistance to Ciprofloxacin, Gonococcal Isolate Surveillance Project (GISP), 2001-2020

Click each state to discover the data

US GC Cipro Map Placeholder
US GC Cipro Map

Reference: Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2020: Gonococcal Isolate Surveillance Project Site-Specific Profiles. Atlanta: U.S. Department of Health and Human Services; 2022